Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Men, Young And Unmarried Ignore Skin Cancer Warnings
Men are twice as likely as women to not protect their skin in the sun, despite more men dying from melanoma than women, according to research due to be released at the British Association of Dermatologists annual conference in Glasgow next month.
generic viagra online
Toshiba Introduces New Multi-Detector CT Systems
Toshiba America Medical Systems, Inc. introduces two advanced multi-detector CT systems, the Aquilion® Premium edition and the Aquilion CX edition. The Aquilion Premium rounds out the company"s CT portfolio to include a product with 160-detector rows and coverage up to 8 cm in a single rotation. This system is also field-upgradeable to an Aquilion ONE. The Aquilion CX is Toshiba"s next generation 64-detector row CT system featuring faster reconstruction standards with up to 28 images per second, Toshiba"s proven Quantum Advantage detector technology and a patient couch that can accommodate up to 660 lbs. The Aquilion Premium and Aquilion CX are both available now.
News of the day
Officials Hope Health Reform Reaches Rural America
Rural Americans are hopeful that health reform includes funding for clinics and health care services in their communities, where the cost of care is often high, CNN reports.
Oncology

Conference: Discovery Partnerships: Academia & Industrial Interactions

Opal Events is proud to present our next exciting conference Drug Discovery Partnerships: Academia & Industrial Interactions , to be held at the Hyatt Regency in Boston on October 28-30, 2009. Early stage drug discovery is a key bottleneck in the pipeline to find novel drugs. With key products suffering patent expiration in coming years, the need for new approaches to accelerate development of new chemical entities to treat severely unmet medical needs is more urgent than ever. This event brings together pharmaceutical companies, universities, small biotechnology enterprises, government agencies, for-profit and not-for profit research institutions to exchange ideas, make connections and discuss opportunities to create an environment that will foster pharmaceutical innovation. Overcome Your Most Critical Challenges in forming Academia-Industrial Partnerships: - Understand Specific Requirements Regarding Investigational New Drug (IND) Application and Approval Process - Maximize the Value and Minimize the Risk by Partnering with the Right Entity - Hear Insider"s Guide to Securing Grant Money for Your Drug Discovery Project - Examine Recent United States Decisions and their Impact on Pharmaceutical and Academia Patenting - Improve Speed to Market with Seamless Alignment on Science and Technology Who Will Attend? Pharmaceuticals, Biotechs, Academia, Foundations, Technology Companies and CRO"s - Managers/ Directors/ VP"s/ Faculty Advisors of: - External Research Collaboration - Scientific Affairs - Business Development - Partnership/ Alliance Management - Office of Technology Transfer - Academic Screening Facilities - School of Medicine/ Life Sciences/ Pharmacy - Grants Manager - Program Officer - Research & Development Sponsorship and Exhibiting Opportunities If you are interested in sponsorship, exhibiting or speaking opportunities, please contact Kay Ye at kye@opalevents.org or 212 532-9898, extension 263. Register Registration is already open on our website here. Sign up today! Opal Events


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009